These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9783882

  • 1. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA, van der Kogel AJ.
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [Abstract] [Full Text] [Related]

  • 2. Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.
    Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Marres HA, de Bree R, van der Kogel AJ, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH.
    J Clin Oncol; 2012 May 20; 30(15):1777-83. PubMed ID: 22508814
    [Abstract] [Full Text] [Related]

  • 3. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
    Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA.
    Radiother Oncol; 1995 Dec 20; 37(3):190-8. PubMed ID: 8746587
    [Abstract] [Full Text] [Related]

  • 4. ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
    Bernier J, Denekamp J, Rojas A, Trovò M, Horiot JC, Hamers H, Antognoni P, Dahl O, Richaud P, Kaanders J, van Glabbeke M, Piérart M.
    Radiother Oncol; 1999 Aug 20; 52(2):149-56. PubMed ID: 10577700
    [Abstract] [Full Text] [Related]

  • 5. ARCON: experience in 215 patients with advanced head-and-neck cancer.
    Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):769-78. PubMed ID: 11849800
    [Abstract] [Full Text] [Related]

  • 6. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO.
    J Clin Oncol; 1999 Oct 01; 17(10):3143-9. PubMed ID: 10506611
    [Abstract] [Full Text] [Related]

  • 7. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M, Piérart M.
    Radiother Oncol; 2000 May 01; 55(2):111-9. PubMed ID: 10799722
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J, Kaanders JH, Van der Kogel AJ.
    Acta Oncol; 1999 May 01; 38(7):875-82. PubMed ID: 10606417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial.
    Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):532-8. PubMed ID: 21300447
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
    Rademakers SE, Hoogsteen IJ, Rijken PF, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, van der Kogel AJ, Bussink J, Kaanders JH.
    Head Neck; 2015 Feb 01; 37(2):171-6. PubMed ID: 24347430
    [Abstract] [Full Text] [Related]

  • 12. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto R, Danesi R, Laddaga M, Del Tacca M, Caciagli P.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):499-504. PubMed ID: 9112444
    [Abstract] [Full Text] [Related]

  • 13. Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
    Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S, Denekamp J, Stratford MR, Dennis MF, Rojas AM.
    Radiother Oncol; 1997 Nov 01; 45(2):159-66. PubMed ID: 9424007
    [Abstract] [Full Text] [Related]

  • 14. Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.
    Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Takes RP, de Bree R, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH.
    Clin Cancer Res; 2014 Mar 01; 20(5):1345-54. PubMed ID: 24452791
    [Abstract] [Full Text] [Related]

  • 15. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
    Hoskin P, Rojas A, Saunders M.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1425-31. PubMed ID: 19036531
    [Abstract] [Full Text] [Related]

  • 16. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
    Hoogsteen IJ, Pop LA, Marres HA, Merkx MA, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):83-9. PubMed ID: 16213107
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.
    Hoskin PJ, Rojas AM, Saunders MI, Bentzen SM, Motohashi KJ, BCON investigators.
    Radiother Oncol; 2009 Apr 01; 91(1):120-5. PubMed ID: 18992952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr 01; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.